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ASSOCIATIONS BETWEEN SERUM LONG-CHAIN OMEGA-3 POLYUNSATURATED 
FATTY ACIDS, HAIR MERCURY AND RISK OF STROKE IN MIDDLE-AGED AND 
OLDER MEN 
 
ABSTRACT 
Stroke is an important chronic disease that leads to morbidity and mortality worldwide. Stroke 
has different subtypes; the most important are ischemic stroke and hemorrhagic stroke. Diet 
may influence the risk of stroke. Fish consumption and omega-3 polyunsaturated fatty acids 
(PUFA) from fish have been suggested to have a protective effect on stroke. However, fish 
may also contain some harmful components, like methylmercury. Most of the previous studies 
focus on the association between fish consumption and stroke risk. In this study serum omega-
3 PUFA, an objective biomarker for intake, was used as exposure. Hair mercury content was 
used as a biomarker for mercury exposure. The associations between serum long-chain 
omega-3 PUFA, hair mercury and risk of stroke were investigated in middle-aged and older 
men. The study cohort included 1871 Finnish men aged 42-60 years from the Kuopio 
Ischemic Heart Disease Risk factor Study (KIHD), who were free of coronary heart disease 
(CHD) and stroke at baseline. During an average follow-up time of 16.1 years, 141 cases of 
stroke occurred, of which 107 were ischemic strokes. In a Cox regression model, there was no 
significant association between serum long-chain omega-3 PUFA concentration and risk of 
stroke. In contrast, the relative risks of stroke in the quartiles of hair methyl-mercury were 1, 
0.95 (95% CI: 0.57-1.59), 1.00 (95% CI: 0.60-1.66) and 1.59 (95% CI: 1.00-2.54) (P for trend 
across quartiles=0.04) after adjusting for age and examination years. Further multivariate 
adjustments only slightly attenuated the associations. No association was found with ischemic 
stroke. In conclusion: this study could not find any association between serum long-chain 
omega-3 PUFA and risk of stroke in middle-aged and older Finnish men free of prior CHD 
and stroke. Mercury exposure was associated with higher risk of stroke. 
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1. Introduction 
Stroke is the leading cause of disability and mortality in the world (Sacco et al. 2013). Since 
four decades ago, the rate of stroke has been higher in economically robust countries rather 
than in low and middle income countries (Norrving and Kissela 2013). For instance, stroke is 
the third-leading cause of death and one of the main factors for disability in the United States 
with more than 140,000 people dying of stroke each year. Stroke is responsible for 
approximately 5.5 million deaths annually, and 44 million disability-adjusted life-years lost. In 
the United States, 795,000 cases suffer from at least one kind of stroke annually, 600,000 of 
these strokes cases are the first incident. First incident stroke cases in the United States are 
similar to those in European countries with annual stroke incidence ranges between 94.6 per 
100,000 population for women and 141.3 per 100,000 population for men (Mukherjee and 
Patil 2011).  
In Finland the incident of stroke has been declined. Stroke is responsible for 8.9% of all deaths 
in Finland. Stroke incident is age dependent disease, Finland with rapid aging population has a 
highest incident of stroke between European countries. The estimation pointed to the 50% 
increase in stroke incident till 2030 due to the increase in the elder population (Meretoja et al. 
2011). According to the cohort studies done by Sivenius et al., in Kuopio and Turku in 1980s 
and 1990s the incident of stroke has been declined which is mostly due to decreases in 
ischemic stroke both in men and women (Sivenius et al. 2009). Although the number of 
elderly people will increase, by improving healthcare and controlling risk factors the burden of 
stroke in 2030 will remain the same as year 2000 in Finland (Sivenius et al. 2009).  
There are different kinds of stroke. Ischemic stroke is the main reason for morbidity and 
mortality in the developed countries with huge financial burden for both family and society 
(Fung et al. 2004, Lucke-Wold et al. 2012). Also, ischemic stroke is the most important stroke 
with long-term disability (Lucke-Wold et al. 2012). Different studies have been carried out to 
investigate associations between risk factors and stroke. Arterial hypertension is the most 
important risk factor for ischemic stroke in the Western countries (Droste et al. 2003). In 78% 
of ischemic stroke patients, with previous known hypertension history, high blood pressure 
has not been controlled (Droste et al. 2003). Also, cigarette smoking is a preventable risk 
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factor for ischemic stroke (Hawkins et al. 2002). Hypercholesterolemia is a risk factor for 
ischemic stroke while the role of cholesterol on hemorrhagic stroke is still inconsistent (Wang 
et al. 2013). A study done in Finland and US showed that controlling smoking, cholesterol and 
diastolic pressure in population level leads to decrease in stroke incidence (Stegmayr et al. 
1997).  
Different studies on the effect of fish consumption and coronary heart disease pointed to the 
dose response association between fish intake and reduced risk factor for cardiovascular 
disease (Kris-Etherton et al. 2003). Effect of fish consumption on stroke is still inconsistent 
(Larsson et al. 2012); this inconsistency may be partly due to the different components in fish 
which can have negative (environmental contaminants, food preparation methods) or positive 
effect (EPA+DHA) on stroke.  
Although fish is an important source of nutrients, there are environmental contaminants such 
as polychlorinated biphenyls, dioxins and methylmercury in the fish. Level of these 
environmental contaminants will be higher in old predatory fish and marine mammals. There 
are different studies pointing to the harmful effects of methylmercury and risk of chronic 
diseases (Virtanen et al. 2007).  
 
2.  Theoretical background 
2.1.  Definition of stroke and types of stroke   
Any distortion and deficit in neurological system with rapidly focal clinical signs lasting for 
24 hours with damaging effect on central nervous system (CNS) or leading to death with 
vascular origin is defined as stroke. Stroke occurs due to blood flow restriction into the brain, 
which may also be called brain attack. Two prominent types of stroke are hemorrhagic and 
ischemic stroke (Sacco et al. 2013). Ischemic stroke is responsible for 80-85% of all stroke 
cases while hemorrhagic stroke is responsible for only 15-20% of all stroke cases. 
Thrombotic, embolic and lacunar are different types of ischemic stroke. Intracerebral and 
subarachnoid are two kinds of hemorrhagic stroke. The most well-known cause of thrombotic 
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stroke is failure in perfusion due to stenosis in major vessels, while embolic stroke is mostly 
due to cardiac failure. Arterial obstruction or small artery disease are the main causes of 
lacunar stroke. Hypertension has main effect as a risk factor on intracerebral hemorrhage and 
vascular malformations is the main etiology of subarachnoid hemorrhage (Zorowitz et al. 
2004). Rupture of blood vessels due to their weakness and bleeding around the brain tissue is 
the major cause of hemorrhagic stroke (Bouzan et al. 2005).  
2.2. Risk factors for ischemic stroke  
High blood pressure, high blood cholesterol level, diabetes, smoking, alcohol use, carotid 
stenosis, and atrial fibrillation are the major modifiable risk factors for ischemic stroke 
(Medline Plus 2013). The most important non-modifiable risk factors for ischemic stroke are 
gender, ethnicity, family history, and age (Sacco 1997, Medline Plus 2013).  
2.3. Age 
Age is an important non-modifiable risk factor for all kinds of stroke, but especially for 
ischemic stroke (Lucke-Wold et al. 2012). Risk of stroke will be doubled for each decades 
after age 55 in both the genders (Sacco et al. 1997). 75% to 89% of strokes occur at the age 
older than 65 years old (Chen et al. 2010). Aging also causes increase in the risk of atrial 
fibrillation, which increases the risk of stroke (Chen et al. 2010). Aging is a process that leads 
to the large number of inflammatory changes. Cytokines are secreted from different cells and 
can have an effect on central nervous system (CNS). Cytokine secretion changes with 
advancing age. Aging causes an increase in secretion of necrosis factor-alpha (TNF- α) - a 
pro-inflammatory cytokine, and decreased interleukin-10 (IL-10) - an anti-inflammatory 
cytokine. Some of the experimental studies done on animals concluded that aging leads to 
increase in some cytokines like TNF-α, interleukin-1α (IL-1 α), IL-6, interleukin-17 (IL-17), 
and interleukin-6R α (IL-6R α) secreted from endothelial cells with damaging effect on 
vascular function and CNS which may have role on stroke incident (Lucke-Wold et al. 2012).  
2.4. Blood pressure 
According to the previous meta-analysis, there is contradictory findings in regard to the 
association between blood pressure and different kinds of stroke (Song et al. 2004). By 
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decreasing every 10 mmHg in systolic blood pressure there should be 30 to 40% reduction in 
stroke incident (Sivenius et al. 2009). A study based on Asian population, found strong 
association between hemorrhagic stroke and blood pressure (Eastern Stroke and Coronary 
Heart Disease Collaborative Research Group 1998) while another study found association 
between both ischemic and hemorrhagic strokes (Lewington et al. 2002). In a cohort study 
there was a strong association between blood pressure and hemorrhagic stroke compared to 
the ischemic stroke (Song et al. 2004).  
The effect of sodium on blood pressure has a dose-response relation (Droste et al. 2003). 
Arterial stiffness may be another factor causing stroke in people with high sodium intake 
(Droste et al. 2003). Sodium may also increase adenosine diphosphate (ADP)-stimulated 
platelet aggregation (Droste et al. 2003). Sodium chloride increases cell protein synthesis and 
cell growth which may lead to increase in collagen synthesis with deposition in heart and renal 
cortex (Droste et al. 2003). Hypertension leads to the major disorders like stroke, myocardial 
infarction and hypertensive nephropathy, vascular remodeling, increase in collagen deposition, 
and atherogenesis effect, hypertension and LDL activated angiotensin-I-receptor (Droste et al. 
2003). In a cohort study done in Kuopio, hypertensive men (blood pressure > 140/90 mmHg) 
without alcohol intake had a 1.72-fold relative risk for any stroke and 1.90-fold relative risk 
for ischemic stroke. Among men with high blood pressure and alcohol intake the relative risk 
for any stroke was 1.86-fold and for ischemic stroke 2.02-fold (Rantakomi et al. 2013). 
2.5.  Cigarette smoking 
Cigarette smoking has more than 4000 chemical components with harmful effects on human 
body (Hawkins et al. 2002). According to the review article done on the association between 
smoking and stroke, association between smoking and ischemic stroke is undeniable while the 
exact mechanism of cigarette smoking and nicotine on ischemic stroke is inconsistent 
(Hawkins et al. 2002). According to the previous studies smoking has association with 
ischemic stroke and subarachnoid hemorrhage (US CDC 2004), while the association between 
smoking and hemorrhagic stroke is not clear (Shah and Cole 2010). A meta-analysis of more 
than 42000 stroke cases from 81 cohort studies found risk of stroke in men and women who 
smoke will be 67% and 83% higher than nonsmokers. Results pointed that cigarette smoking 
is a prominent and modifiable risk factor of stroke with same hazard of stroke in both men and 
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women, however results showed greater relative hazard of hemorrhagic stroke in women 
rather than men (Peters et al. 2013). Smoking leads to the changes in cerebral blood flow, 
damages blood brain barrier and changes in cerebrovascular endothelium (Hawkins et al. 
2002), which are prominent factors that increase the risk of stroke. According to a meta-
analysis, smokers have higher possibility for stroke incidence when compared to nonsmokers 
(Hawkins et al. 2002). Endothelin is a peptide secreted from endothelial cells with 
vasoconstrictor effect. Endothelin is a mediator with effect on ischemic stroke (Hawkins et al. 
2002). 
2.6. Serum Cholesterol 
Hypercholesterolemia is a modifiable risk factor for ischemic stroke (Goldstein et al. 2011), 
while there is inconsistency in association between serum cholesterol level and intracerebral 
hemorrhage and subarachnoid hemorrhage (Wang et al. 2013). A Japanese study was the first 
study which found an inverse association between serum cholesterol level and hemorrhagic 
stroke (Puddey 1996). Collaborative analysis of 12 Asian cohort studies found that, 0.6 
mmol/L decrease in cholesterol concentrations leads to 27% increase in risk of hemorrhagic 
stroke (Eastern Stroke and Coronary Heart Disease Collaborative Research Group 1998) while 
Korea Medical Insurance Corporation Study found no association between low total serum 
cholesterol level and risk of hemorrhagic stroke (Suh et al. 2001). Wang et al. found an 
inverse association between total cholesterol and hemorrhagic stroke, also they found inverse 
association between LDL-C and hemorrhagic stroke while they could not find any significant 
association between HDL-C and risk of hemorrhagic stroke (Wang et al. 2013).  
2.7. Alcohol 
Association between alcohol consumption and ischemic stroke has been shown to be a J or U 
shaped, while the association with hemorrhagic stroke has been shown to be linear. Effect of 
high alcohol intake on the increased risk of stroke may occur because of inducement 
hypertension, cardiomyopathy and atrial fibrillation through alcohol consumption while 
moderate consumption increase high density lipoprotein (HDL) and decreasing platelet 
aggregation (Reynolds et al. 2003). Recently, Rantakomi et al., (Rantakomi et al. 2014) found 
an association between the frequency of alcohol intake and stroke mortality. They showed the 
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highest risk of stroke death among men who consumed alcohol >2.5 times/week. Among those 
men who consumed alcohol 0.5 –2.5 times/ week, the risk of stroke death was only slightly 
increased and the association was not statistically significant.  
2.8. Diabetes 
Diabetes mellitus is a well-known risk factor for stroke. Most of the epidemiological studies 
have found strong association between type 2 diabetes mellitus and stroke (Janghorbani et al. 
2007). Association between diabetes and hemorrhagic stroke remains inconsistent while there 
are reports that found positive association between diabetes and changes in cerebral vessels 
(Jorgensen et al. 1994). Most of the studies found type 2 diabetes as an important risk factor 
for ischemic stroke while there is not strong evidence in regard to the association between type 
2 diabetes and hemorrhagic stroke (Hu et al. 2005). According to a cohort study, there was 
association between stroke and both two types of diabetes mostly with type 1 diabetes 
(Janghorbani et al. 2007). The higher incidence of stroke subtype in patients with type 1 
diabetes may explain by younger age at onset, insulin deficiency, hypertension followed by 
nephropathy (Hu et al. 2005). Reports from a meta-analysis of 26 prospective studies showed 
an association between chronic hyperglycemia and increased risk of all-cause mortality and 
cardiovascular outcomes in type 2 diabetes (Zhang et al. 2012). They found that every 1% 
increase in glycohemoglobin, was associated with a 15% increase in risk of all-cause 
mortality, 25% in CVD mortality, 17% in CVD, 15% in CHD, 17% in fatal CHD, 11% in 
heart failure and 11% in stroke (Zhang et al. 2012). This result was consistent with results 
from meta-analysis of 10 prospective studies. The only difference was the higher risk of stroke 
(17%) (Selvin et al. 2004).  
2.9. Atrial fibrillation 
Atrial fibrillation is one of the most common arrhythmias in adults (Guerra et al. 2013). Atrial 
fibrillation is responsible for 1/6 of all stroke cases (Armaganijan et al. 2012). Atrial 
fibrillation alone is associated with a 3- to 4-fold increased risk of stroke after adjustment for 
other vascular risk factors (Goldstein et al. 2006). Fibrillatory activity may occur due to the 
irregular atrial response to the reentry circuit. Omega 3 long chain PUFA, especially DHA and 
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EPA are constituents of biological membrane and reduce membrane fluorescence anisotropy 
by increasing cell membrane fluidity, reduce oxidative stress also has direct 
electrophysiological effect on some of ion channels like sodium and ultra-rapid potassium 
currents, and the sodium–calcium exchanger (Patti et al. 2006). Any sustainable changes in 
arterial function defined as atrial remodeling. Atrial fibrillation or heart failure conditions, 
myocardial infarction, and cardiomyopathy leads to the atrial remodeling.  
The effect of dietary lipids on arrhythmia has been known from 25 years ago. In 1988 an 
experimental study on rabbit reported the lowering effect of polyunsaturated alpha-linoleic 
acid on arrhythmia threshold (McLennan et al. 1988). Experimental study pointed to the effect 
of PUFA on reducing atrial electrical remodeling also reducing structural changes in the atria 
(Savelieva et al. 2010). 
2.10. Dietary factors 
2.10.1 Fat intake 
Intake of fats has effects on blood lipids, blood pressure, endothelial function and 
inflammation (Strazzullo et al. 2004). Most of the studies underline the importance of type of 
fat intake rather than total fat intake (Strazzullo et al. 2004). Association between dietary fat 
intake and stroke is still inconsistent (Strazzullo et al. 2004).   
A cohort study done on 43732 men aged 40-75 years and followed up for 14 years did not find 
an association between intakes of total fat, animal fat, vegetable fat, saturated fat, 
monounsaturated fat, polyunsaturated fat, trans unsaturated fat intake and risk of ischemic and 
hemorrhagic stroke (He et al. 2003). Previous studies found a positive association between 
dietary saturated fatty acid intake and risk of stroke and carotid artery thickness (Tell et al. 
1994, Sasaki et al. 1995). However Yamagashi et al., (Zorowitz et al. 2004) found an inverse 
association. A meta-analysis of 21 cohort studies did not find an association between SFA 
intake and stroke risk (Siri-Tarino et al. 2010). In a prospective nested case-control study, the 
positive association between plasma SFA as a biomarker of dietary fatty acids intake and 
stroke has been mentioned (Iso et al. 2002).  
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Association between serum monounsaturated fatty acids and stroke is inconsistent. Results 
from multicenter case control study (Ricci et al. 1997) also Framingham Heart Study, a 
population-based cohort study with 20 years follow up of men (Gillman et al. 1997) found an 
association between high risk of stroke and low levels of oleic acid in blood cells membrane, 
however cohort study done by He et al., did not find this association (He et al. 2003) . Cohort 
study done on 87025 postmenopausal women with 7.6 years follow-up did not find any 
association between intake of saturated, mono unsaturated and polyunsaturated fatty acids and 
total stroke or ischemic stroke (Yaemsiri et al. 2012). Framingham study found adverse effect 
between monounsaturated fatty acids and stroke (Gillman et al. 1997). Other studies could not 
find association between intake of monounsaturated fatty acids and polyunsaturated fatty acids 
and stroke (Iso et al. 2001, Iso et al. 2002, He et al. 2003, Iso et al. 2003, Sauvaget et al. 2004, 
Leosdottir et al. 2007). 
Linoleic acid is one of the major polyunsaturated fatty acids in human diet with defined effect 
on total cholesterol and LDL cholesterol (Strazzullo et al. 2004). Two nested case-control 
studies found inverse association between serum linoleic acid (Iso et al. 2002) and also serum 
α-linolenic acid (Simon et al. 1995) and risk of stroke. In a US study there was no association 
between ALA intake and risk of stroke (He et al. 2002). In a Dutch study low ALA intake was 
associated with increased risk of stroke (de Goede et al. 2011). In a study done by Strazzullo 
et al., (Strazzullo et al. 2004), serum α-linolenic acid was selected as a biomarker to study the 
effect of omega-3 PUFA on stroke. Results showed inverse association between serum α-
linolenic acid and risk of stroke through decreasing in plaque formation and carotid thickness.  
2.10.2 Fish Intake 
Fish is a good source of protein, selenium, vitamin D, other minerals and vitamins. Fish may 
contain beneficial components that some of them do not exist in supplements so 
recommendations are to use fish rather than supplements. Fish intake have not only protective 
effect on the human body through omega 3 long chain polyunsaturated fatty acids but there 
may be some damaging effect through some toxic pollutants in fish like methylmercury 
(MeHg).  
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According to the American Heart Association 2020 report, consumption of at least 2-3.5-oz 
servings/week of fish, especially oily fish, is good for ideal cardiovascular health. Fish, 
especially fatty fish, are a prominent source of omega-3 polyunsaturated fatty acid (PUFA), 
EPA (20:5n-3) and DHA (22:6n-3) (Mozaffarian and Wu 2011). Level of long chain omega-3 
PUFA differs among the fish type. Mackerel, salmon, red mullet have the highest content of 
omega-3 polyunsaturated fatty acids (Domingo et al. 2007). Table 1 shows first 10 fish species 
with high amount of omega-3 PUFA. Circulating DPA level is poorly related to the fish intake 
and diet but mostly as a metabolite of EPA. There are few studies found inverse association 
between DHA and chronic diseases (Mozaffarian and Wu 2011).  
Table 1. EPA, DPA, DHA concentration in different fish 
Fish EPA 
mg/100g 
DPA mg/100g DHA mg/100g EPA+DHA 
mg/100g 
Anchovy  763 41 1,292 2,055 
Herring 909 71 1,105 2.014 
Salmon, farmed 862 393 1,104 1,966 
Salmon, wild  411 368 1,429 1,840 
Mackerel, Atlantic  504 1106 699 1,203 
Bluefish 323 79 665 988 
Sardines, Atlantic 473 0 509 982 
Trout 259 235 677 936 
Golden bass (tilefish) 172 143 733 905 
Swordfish 127 168 772 899 
Data from the U.S. Department of Agriculture National Nutrition Database for Standard 
Reference Release 23, 2010. (U.S. Department of Agriculture 2010) 
The study in Greenland Eskimos was a pioneer study on the association between fish intake 
and the low incident of stroke (Bang et al. 1976). Ecological studies found inverse association 
between long-chain omega-3 polyunsaturated fatty acids and ischemic stroke while positive 
association with hemorrhagic stroke (He et al. 2004). According to the reports from a meta-
analysis done on 16 prospective cohort studies, consisting of 402127 individuals aged between 
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30 and 103 years with 10568 incident stroke cases (Xun et al. 2012), a nonlinear association 
was found between fish intake and stroke. According to the meta-analysis of 15 prospective 
studies (seven studies were conducted in the United States, 4 in Europe, 3 in Japan, and 1 in 
China) with 9360 stroke events and 383838 participants, 9 studies reported RR of 0.90 in 
those with 3 servings fish intake/week for both ischemic and hemorrhagic stroke. Results 
found weak inverse association between fish intake and risk of stroke (Larsson and Orsini 
2011). 
Different cohort studies found association between long chain omega-3 PUFA intake and 
lower risk of stroke (Iso et al. 2001, He et al. 2002, Larsson et al. 2012). Cohort study done by 
Mozaffarian et al., in 65 years or older men and women found that tuna and other fish have 
inverse association with ischemic stroke however there was not any association with 
hemorrhagic stroke. Fried fish and fish sandwiches had positive association with total and 
ischemic stroke also using baked and broiled fish reduces the risk of total and ischemic stroke 
while fried fish, increased the risk of stroke (Mozaffarian et al. 2005). However a prospective 
study found conflicting result regard to the association between fish intake and risk of stroke, 
which may because of methodological differences (Larsson et al. 2011). Methodological 
differences were mostly because of method of fish preparation (deep fried fish), also fish type 
(salted fish), which may attenuate all healthy impact of fish consumption (Atkinson et al. 
2011, Larsson and Orsini 2011). Cohort study done by Folsom et al, in 41,836 postmenopausal 
women aged 55–69 years pointed to positive association between the greater fish intake and 
younger age; greater education, physical activity, alcohol consumption, estrogen use, vitamin 
use, body mass index, and hypertension. In this study there was not any association between 
intake of marine omega-3 fatty acids and total mortality also with coronary heart disease and 
stroke mortality (Folsom and Demissie 2004). Moreover, in a Chinese cohort study (Yuan et 
al. 2001), prospective population cohort study in the UK (Myint et al. 2006) and in a Finnish 
study (Montonen et al. 2009) no association were found (Table 2). 
There are few studies done on the effect of eicosapentaenoic acid (EPA) and docosahexaenoic 
(DHA) intake from fish. In a study done by de Goede et al., an inverse association was found 
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between EPA+DHA and fish intake with risk of all subtypes of stroke in women while these 
associations were not significant in men (de Goede et al. 2012) (Table 2). 
In a randomized control trial 11,324 patients surviving recent myocardial infarction, results 
could not find any association between long-chain omega-3 PUFA supplementation and stroke 
(Gissi 1999). Randomized, double-blind intervention trial done in patients from 11 different 
dialyses centers in Denmark could not find association between omega 3 supplementation and 
risk of stroke (Svensson et al. 2006). Randomized control trial done in men and women with 
18 years and older in Italy could not find association between stroke and long-chain omega-3 
PUFA (Gissi et al. 2008). In a RCT done in France, result could not find any significant 
association between long chain omega-3 PUFA supplementation and risk of stroke (Galan et 
al. 2010) (Table 3). 
Only few studies have used objective biomarkers of fish and long-chain omega-3 PUFA intake 
as exposure. According to the study done by Mozaffarian et al., among different n3-PUFA 
biomarkers, DHA and Total n3-PUFA strongly associated to ischemic stroke incident without 
any association with total and hemorrhagic stroke (Mozaffarian et al. 2013). 
Cell lipids has effect on cellular functions. Omega 3 PUFA as one of the cell lipids, has effect 
on molecular and Ion channels also on phospholipids of cell membrane with changing in 
physiochemical properties of the membrane rafts and caveolae. It resulted to the membrane 
protein function which may describe anti- inflammatory and anti-arrhythmic effect of omega 3 
PUFA. Omega 3 PUFA can effect on the ion channels directly or through the effect on lipid 
membrane. Animal experimental study showed omega 3 PUFA directly affects myocyte 
electrophysiology (like changing the function of membrane sodium channel, L-type calcium 
channel, and sodium–calcium exchanger) and effect on myocyte excitability especially in 
ischemic cells and trigger arrhythmia (Mozaffarian and Wu 2011). 
There are different mechanisms that describe the beneficial effect of omega 3 PUFA on 
chronic diseases like CVD (Mozaffarian and Wu 2011). There is linear relation between 
dietary intake of omega 3 PUFA for less than 750 mg/day and decreasing in heart rate, blood 
pressure and arrhythmia. Reports from population-based observational studies showed inverse 
associations between high intake of fish or polyunsaturated fatty acids through fish 
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consumption and blood pressure in general population and in healthy, non-hypertensive 
participants (Pauletto et al. 1996, Mozaffarian et al. 2006, Virtanen et al. 2012). 
 Randomized control trials could not find the association between omega-3 supplementation 
and all causes mortality, cardiac death and stroke (Rizos et al. 2012). Also, meta-analysis of 8 
prospective studies could not find any significant association between omega-3 supplements 
and stroke (Larsson et al. 2012). 
Possible mechanism for decreasing HR and arrhythmia is increase in myocardial efficiency, 
left ventricular diastolic filling and autonomic function. Decrease in systematic vascular 
resistance and endothelial dysfunction and increase in vasodilatory response and arterial wall 
compliance and decrease in endothelial dysfunction and systemic vascular resistance are the 
possible mechanism to reduce blood pressure. The possible mechanism for decrease in 
thrombosis are decrease in production of arachidonic acid derived eicosanoids (Mozaffarian 
and Wu 2011). Intake of higher dose (at least up to 7g/d) has linear relation with decreasing 
triglyceride production. The beneficial effect of omega 3 PUFA on thrombosis is just in the 
format of high supplementary intake (more than 4 g/d) (Goldstein et al. 2011). 
There are consistent results in association between fish consumption and coronary heart 
disease in different studies while there is inconsistency between results of randomized control 
trials and meta-analysis of cohort studies in regard to the association between fish 
consumption and risk of stroke (Mozaffarian and Wu 2011). This inconsistency may occur 
because of some residual confounding in the observational studies, inadequate statistical 
power in trials or insufficient follow up time in trials, or because of beneficial components 
exist in fish and not in fish oil (Mozaffarian and Wu 2011).  
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Table 2.  Characteristics of prospective cohort studies of dietary fish or long-chain omega-3 PUFA intake, circulating long-chain 
omega-3 polyunsaturated fatty acid levels and risk of stroke 
study Study name No of 
participants 
Age Follow 
up, y 
Exposure Categories Outcome (No. 
of Events) 
RR (95 % 
CI) 
for 
highest 
vs. 
lowest 
category 
for total 
stroke 
RR (95 % 
CI) 
for highest 
vs. 
lowest 
category for 
Ischemic 
stroke 
RR (95 % CI) 
for highest vs. 
lowest category 
for 
hemorrhagic 
stroke 
Fish intake 
Larsson et al 2011 
Swedish 
Mammography 
Cohort 
(Larsson and 
Orsini 2011) 
 
Fish consumption and 
risk of stroke in Swedish 
women 
34670 49-83 10.4 < 1serving/week 
1-1.4 Serving/week 
1.5-2 Serving/week 
2.1-3 Serving/week 
>3 Serving/week 
Total stroke = 
1680 
Ischemic 
stroke = 1310 
Hemorrhagic 
stroke = 137 
Unclassified 
stroke = 125 
0.72 
(0.57-
0.92) 
0.87 (0.73-
1.04) 
0.67 (0.42-
1.08) 
Montonen et al 
2009 
Finland 
(Montonen et al. 
2009) 
Fish consumption and 
the incidence of 
cerebrovascular disease 
3958 40-79 28 6 (median g/day) 
18 (median g/day) 
32 (median g/day) 
72 (median g/day) 
Total stroke = 
659 
Ischemic 
stroke = 364 
Hemorrhagic 
1.01 
(0.81-
1.27) 
0.99 (0.73-
1.35) 
1.23 (0.63-
2.42) 
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stroke = 120 
Unclassified 
stroke = 175 
Myint et al, 2006 
Norfolk, UK 
cohort of the 
European 
Prospective 
Investigation into 
Cancer 
Habitual fish 
consumption and risk of 
incident stroke: the 
European Prospective 
Investigation into Cancer 
(EPIC)-Norfolk 
prospective population 
study 
24312 40-79 8.5 <1 portion/week 
1-2 portion/week 
>2 portion/week 
Total stroke = 
421 
Women: 
0.86 
(0.60-
1.24) 
 
Men: 1.34 
(0.93-
2.93) 
- - 
Mozaffarian et al., 
2005 
(Mozaffarian et al. 
2005) 
Fish Consumption and 
Stroke Risk in Elderly 
Individuals: 
 
4775 65-98 12 Once/mo 
1-3 times/mo 
1-4 times/week 
≥ 5times/week 
Total stroke = 
626 
Ischemic 
stroke = 529 
Hemorrhagic 
stroke = 65 
Unclassified 
stroke = 32 
0.72 
(0.53-
0.98) 
0.68 (0.48-
0.95) 
- 
Folsom et al., 
2004, The Iowa 
Women’s Health 
Study cohort 
French 
(Folsom and 
Demissie 2004) 
Fish intake, marine 
omega-3 fatty acids, and 
mortality in a cohort of 
postmenopausal women 
41836 55-69 14 < 0.5 serving/week 
0.5-1.0 
serving/week 
1.0-1.5 
serving/week 
1.5-2.5 
serving/week 
Total stroke = 
313 
1.06 
(0.67-
1.67) 
- - 
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>2.5 serving/week 
He et al 2002  
Health 
Professional 
Follow-Up Study 
USA  
(He et al. 2002) 
Fish consumption and 
risk of stroke in men 
43671 40-75 12 < once/month 
1-3 times/month 
once/week 
2-4 times/week 
> 5 times/week 
Total stroke = 
608 
Ischemic 
stroke = 377 
Hemorrhagic 
stroke = 106 
Unclassified 
stroke = 125 
0.83 
(0.53-
1.29) 
0.54(0.31-
0.94) 
1.55 (0.45-
5.35) 
Iso et al 2001 
Nurses’ Health 
Study 
USA 
(Iso et al. 2002) 
Intake of fish and 
omega-3 fatty acids and 
risk of stroke in women 
79 839 34-59 14 < once/mo 
1-3 times/mo 
once/week 
2-4 times/week 
> 5 times/week 
Total stroke = 
574 
Ischemic 
stroke = 303 
Hemorrhagic 
stroke = 181 
0.72 
(0.53-
0.99) 
0.67 (0.42-
1.07) 
Could not find 
association 
Yuan et al 2001 
Shanghai, China 
(Yuan et al. 2001) 
Fish and shellfish 
consumption in relation 
to death from myocardial 
infarction among men in 
Shanghai, China 
18244 45-64 12 <30 (g/week) 
30<60 (g/week) 
60<100 (g/week) 
100<150(g/week) 
≥150(g/week) 
Total stroke = 
480 
1.05 
(0.77-
1.43) 
- - 
EPA+DHA 
de Goede et al., 
20121 
(de Goede et al. 
Gender-Specific 
Associations of Marine 
n-3 Fatty Acids 
20069 20-65 8-13 Women 1 
Q1 < 57 mg/d 
Q2 57–106 mg/day 
Total stroke = 
221 
Ischemic 
Women: 
0.49 
(0.27-
Women: 
0.62 (0.29-
1.35) 
Women: 0.45 
(0.14–1.42) 
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2012) 
 
and Fish Consumption 
with 10-Year Incidence 
of Stroke 
Q3 107–188 mg/day 
Q4 > 188 mg/day 
Men 
Q1< 66 mg/day 
Q2 66-118 mg/day 
Q3 119-198 mg/day 
Q4 > 199 mg/day 
stroke = 142 
Hemorrhagic 
stroke = 47 
Unclassified 
stroke = 32 
0.91) 
 
Men: 0.87 
(0.51-
1.48) 
 
Men: 0.85 
(0.45-1.60) 
Men: 0.28 
(0.05–1.46) 
          
He et al 2002 
Health 
Professional 
Follow-Up Study 
USA 
(He et al. 2002) 
Fish consumption and 
risk of stroke in men 
43671 40-75 12 < 0.05 g/day 
0.05 < 0.2 g/day 
0.2 < 0.4 g/day 
0.4 < 0.6 g/day 
≥ 0.6 g/day 
Total stroke = 
608 
Ischemic 
stroke = 377 
Hemorrhagic 
stroke = 106 
Unclassified 
stroke = 125 
 0.73(0.43-
1.25) 
1.14 (0.34-
3.84) 
Yuan et al 2001 
Shanghai, China 
(Yuan et al. 2001) 
Fish and shellfish 
consumption in relation 
to death from myocardial 
infarction among men in 
Shanghai, China 
18244 45-64 12 <0.27 g/week 
0.27–0.43 g/week 
0.44–0.72 g/week 
0.73–1.09 g/week 
≥ 1.10 g/week 
Total stroke = 
480 
1.01 
(0.75-
1.33) 
- - 
circulating long-chain omega-3 polyunsaturated fatty acid levels 
Mozaffarian et al., 
2013 
(Mozaffarian et al. 
Plasma phospholipid 
long-chain ω-3 fatty 
acids and total and 
2,692 75±5 1 to 5 Total stroke = 406 
Ischemic stroke = 
319 
EPA: 1.09 
(0.76–1.57) 
DHA: 0.74 
EPA: 0.70 
(0.30–
1.67) 
- - 
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2013) cause-specific mortality 
in older adults: a cohort 
study. 
 
Hemorrhagic stroke 
= 65 
Unclassified stroke 
= 22 
(0.50–1.10) 
DPA: 0.78 
(0.55–1.10) 
DHA: 
1.24 
(0.52–
2.94) 
DPA: 
0.66 
(0.32–
1.35) 
 
1 According to the EPA, DHA intake 
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Table 3.  Characteristics of RCT studies of dietary long-chain omega-3 PUFA intake and risk of total stroke 
Study, country Intervention omega-3 
dose, g/d 
EPA,  
g/d 
DHA, 
 g/d 
Vitamin E, 
mg/d 
Control Duration,  
y 
No of participants, 
Treatment/Control 
HR (95 
% CI) 
Galan et al., 
(SU.FOL.OM3) 
2010, (France) 
(Galan et al. 2010) 
 0.6 0.4 0.2 - Placebo  4.7 1253/1248 1.04 
(0.62-
1.75) 
Gissi et al., , 2008,  
(Italy) 
(Gissi et al. 2008) 
850-882 mg 
EPA+ DHA 
(ratio: 1:1.2) 
1 - - - Placebo 3.9 3494/3481 1.16 
(0.89–
1.51) 
Svensson et al., 
2006, (Denmark) 
(Svensson et al. 
2006) 
Omacor (45% 
EPA, 37.5% 
DHA) 
1.7 0.77 0.64 - Placebo (olive 
oil) 
2 103/103 2.23 
(0.58-
8.46) 
Gissi et al., 1999,  
(Italy) 
(Gissi 1999) 
850-882 mg 
EPA+ DHA 
(ratio: 1:1.2) 
1 - - 300 Placebo 3.5 PUFA intake 2836 
/2828 
Vitamin E intake: 
2830/2828 
1.30 
(0.87-
1.96) 
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2.11. Pollutants and stroke 
Mercury (Hg) is a heavy metal. Elemental or metallic Hg, inorganic and organic Hg are three 
forms of Hg. Hg is produced by burning fossil fuels, industrial waste, volcano, municipal 
waste combustion and gold mining. It is a volatile metal and can remain in the atmosphere for 
about one year (Virtanen et al. 2007). Methylmercury (MeHg) is a highly toxic form of Hg 
which bioaccumulates in the fish and marine mammals (100% of Hg in fish is in the format of 
MeHg) (Roman et al. 2011). MeHg level will be higher in older and predatory fish like sharks, 
tuna, swordfish and pike (Virtanen et al. 2007) (Table 4). 
Table 4. Mercury levels in selected fish 
Species Mercury concentration (mg/kg) 
Mean Range Reference 
Burbot 0.22–0.26 0.20–0.37 (E.-R. Venalainen) 
Catfish 0.05 ND–0.31 (US Department of Health and Human 
Services and US Environmental 
Protection Agency) 
Cod 0.10–0.11 ND–0.42 (US Department of Health and Human 
Services and US Environmental 
Protection Agency) 
Herring 0.04 ND–0.14 (US Department of Health and Human 
Services and US Environmental 
Protection Agency) 
Mackerel, king 0.73 0.23–1.67 (US Department of Health and Human 
Services and US Environmental 
Protection Agency) 
Perch, 
freshwater 
0.14 ND–0.31 (E.-R. Venalainen) and (US Department 
of Health and Human Services and US 
Environmental Protection Agency) 
Perch, ocean ND ND–0.03 (US Department of Health and Human 
Services and US Environmental 
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Protection Agency) 
Pike 0.38–0.40 0.15–0.85 (E.-R. Venalainen) 
Pike–perch 0.11–0.30 0.06–0.37 (E.-R. Venalainen) 
Pollock 0.04 ND–0.78 (US Department of Health and Human 
Services and US Environmental 
Protection Agency) 
Salmon 0.01–0.07 ND–0.19 and (US Department of Health and 
Human Services and US Environmental 
Protection Agency) 
Sardine 0.02 0.004–0.35 (US Department of Health and Human 
Services and US Environmental 
Protection Agency) 
Shrimp ND ND–0.05 (US Department of Health and Human 
Services and US Environmental 
Protection Agency) 
Shark 0.99 ND–4.54 (US Department of Health and Human 
Services and US Environmental 
Protection Agency) 
Swordfish 0.98 ND–3.22 (US Department of Health and Human 
Services and US Environmental 
Protection Agency) 
Tilefish 1.45 0.65–3.73 (US Department of Health and Human 
Services and US Environmental 
Protection Agency) 
Trout, 
freshwater 
0.07 ND–0.68 (E.-R. Venalainen) and (US Department 
of Health and Human Services and US 
Environmental Protection Agency) 
Tuna 0.38 ND–1.30 (US Department of Health and Human 
Services and US Environmental 
Protection Agency) 
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Whitefish 0.03–0.08 ND–0.31 (E.-R. Venalainen) and (US Department 
of Health and Human Services and US 
Environmental Protection Agency) 
ND=mercury concentration below the detection level (0.01 mg/kg) (Virtanen et al. 2007) 
MeHg is metabolized to inorganic Hg and is excreted via feces slowly, so the half-life of 
MeHg in human body is 70-80 days (Virtanen et al. 2007). Hg is converted to MeHg in the 
water-sources by microorganisms’ reaction. MeHg exposure leads to oxidative stress and 
production of reactive oxygen species (ROS) which can lead to blockage of arteries and have a 
negative effect on central nervous system (CNS) and also increase risk of CVD, arrhythmias, 
hypertension and ischemia (Salonen et al. 1995, Virtanen et al. 2005, Virtanen et al. 2007, 
Roman et al. 2011). Hg has high affinity to the sulfhydryl groups, which inactive enzymatic 
reaction, sulfur containing antioxidants also sulfur amino acids and leads to decreasing 
oxidative defense reaction and also endothelial dysfunction (Virtanen et al. 2005, Houston 
2011). Some studies found association between MeHg and oxidized low density lipoprotein 
(LDL) (Salonen et al. 1995). Hg exposure may induce hypertension through inactivation of 
catecholamine-0-methyl transferase, which leads to elevating rate of epinephrine, 
norepinephrine and dopamine in urine and serum (Houston 2011). However, recent 
prospective cohort studies have not found an association between mercury exposure and blood 
pressure (Mozaffarian et al. 2012, Virtanen et al. 2012).  
Some studies suggest a protective effect of selenium in fish which can attenuate the negative 
effect of MeHg by binding to Hg and making seleno-mercury complex which is less toxic 
(Houston 2011).  
KIHD was the pioneer study on the association between MeHg exposure and risk of CVD in 
middle-aged men (Virtanen et al. 2005). MeHg can attenuate the positive effect of omega-3 
polyunsaturated fatty acids (Virtanen et al. 2005, Wennberg et al. 2012). Result from 
prospective population-based study found that high mercury will attenuate the beneficial effect 
of fish on cardiovascular health (Virtanen et al. 2005) while cohort study done by Mozaffarian 
et al., could not find any association (Mozaffarian et al. 2011). Also result from cohort study 
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done in US could not find any significant association between hair mercury and risk of stroke 
(Mozaffarian et al. 2011). There is few information available regard to Hg and stroke risk.  
 
3. Aims 
The aim of this study is to investigate the association between serum long-chain omega-3 
polyunsaturated fatty acids, hair Hg and risk of stroke in middle-aged and older men.  
 
4. Subjects, participants and methods  
4.1 Study population 
KIHD is a population based, randomly selected sample of men from eastern Finland. It has 
been designed to explore the associations between risk factors and risk of CVD, 
atherosclerosis, stroke and other chronic diseases (Salonen 1988). The baseline examinations 
were performed in 1984–1989 (Salonen 1988). A total of 2682 men who were 42, 48, 54 or 60 
years old at baseline (82.9 % of those eligible) were recruited in two cohorts. The first cohort 
consisted of 1166 men who were 54 years old, enrolled between 1984 and 1986, and the 
second cohort included 1516 men who were 42, 48, 54 or 60 years old, enrolled between 1986 
and 1989. During the years 1998-2001 all men from the second cohort were invited to the 11-
year re-examinations of the study, and 854 men (85.6%) participated. The KIHD study 
protocol was approved by the Research Ethics Committee of the University of Kuopio and 
complies with the Declaration of Helsinki. All subjects gave written informed consent for 
participation. 
Subjects with history of CHD at baseline (n= 677) and history of stroke at baseline (n=32) or 
with missing data on dietary intakes (n=23), serum long-chain n-3 PUFA (n =122), hair 
mercury (n= 14) were excluded, leaving 1814 men. 
4.2 Serum fatty acids measurements 
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Serum esterified and non-esterified fatty acids were specified in one gas chromatographic run 
without pre separation as described (Laaksonen et al. 2002). Chloroform-methanol used to 
extract serum fatty acids. Quantification done with reference standards purchased from Nu-
Check Prep Inc. (MN, USA). Each analyte had specified reference standard and recovery of 
analytes was confirmed with an internal standard eicosan (arachidic acid C20H40O2). Fatty 
acids were chromatographed in an NB-351 capillary column (HNU-Nordion, Helsinki, 
Finland) by a Hewlett-Packard 5890 Series II gas chromatograph (Hewlett-Packard Company, 
Avondale, Pa, USA, since 1999 Agilent Technologies Inc., USA) with a flame ionization 
detector. The coefficient of variation (CV) for repeated measurements of major esterified fatty 
acids was about 5%. Because the relative degree of saturation of fatty acids varies among 
esterified fatty acid types (i.e., cholesterol esters, phospholipids, and triglycerides), the 
esterified fatty acid concentrations were adjusted for serum low-density lipoprotein 
cholesterol, high-density lipoprotein cholesterol, and triglyceride concentrations. The CV for 
major nonesterified fatty acids was about 15%. No adjustment was conducted for nonesterified 
fatty acids. Results were obtained in mmol/L. Sum of EPA (20:5n-3), docosapentaenoic acid 
(DPA, 22:5n-3) and DHA (22:6n-3) considered as total long-chain n-3 PUFA. 
4.3 Other Measurements 
The subjects gave fasting blood samples between 8 and 10AM on the baseline examinations in 
1998-2001. They were instructed to abstain from ingesting alcohol for three days and from 
smoking and eating for 12 hours prior to giving sample. Detailed descriptions of the 
determination of blood glucose, (Salonen 1988) assessment of medical history and 
medications, (Salonen 1988) family history of diseases, (Salonen 1988) smoking,(Salonen 
1988) and alcohol consumption, (Salonen 1988) have been published. Diabetes was defined as 
self-reported diabetes mellitus or fasting blood glucose of 6.7 mmol/L or more. Education was 
assessed in years by using self-administrated questionnaire. Physical activity was assessed 
using the KIHD 12-Month Leisure-Time Physical Activity Questionnaire (Lakka et al. 1994). 
Body mass index (BMI) was computed as the ratio of weight in kilograms to the square of 
height in meters. Dietary intake of foods and nutrients was assessed at the time of blood 
sampling using 4-day food recording (Voutilainen et al. 2001). Mercury in hair was 
29 
 
determined by flow injection analysis-cold vapor atomic absorption spectrometry and 
amalgamation, as described (Salonen et al. 1995). 
4.4 Ascertainment of follow-up events 
Incident strokes between years 1984-1992 were observed through FINMONICA stroke 
register, Information regarding the stroke incident between years 1993 and 2004 was collected 
through computerized linkage to the national hospital discharge registry. The diagnosis of 
stroke was based on sudden onset of clinical signs or focal or global disturbance of cerebral 
function lasting 24 hours (except in the case of sudden death or if interrupted by surgical 
intervention) with no apparent cause other than a vascular origin. Each suspected stroke 
(International Classification of Diseases [ICD]-9 codes 430_439 and ICD-10 codes I60–I68 
and G45–G46) was classified into 1) a definite stroke, 2) no stroke, or 3) an unclassifiable 
event. The FIN-MONICA stroke register data were annually rechecked with the data obtained 
from the computerized national hospital discharge and death registers. Definite strokes and 
unclassifiable events were included in the group of any stroke. Each definite stroke was 
classified into 1) an ischemic stroke (ICD-9 codes 433 434; ICD-10 code I63) or 2) a 
hemorrhagic stroke (ICD-9 codes 430 431; ICD-10 codes I60–I61). If the subject had multiple 
nonfatal strokes during follow-up, the first stroke was considered as the end point. CT was 
performed in 90% of the patients by 1993, and CT, MRI, and autopsy reached 100% by 1997. 
Every resident of Finland has a unique personal identifier that is used in registers. There were 
no losses to follow-up (Karppi et al. 2012). 
4.5 Statistical analysis 
Subjects were divided into quartiles according to the mean serum omega 3 PUFA (0-0.64, 
0.65-1.26, 1.27-2.50, 2.51-15.67 % of all serum fatty acids) and the mean mercury content in 
hair (1.70-3.63, 3.63-4.34, 4.34-5.34, 5.34-15.59 µg/g of hair). The univariate relationships 
between serum EPA + DPA + DHA and hair mercury and baseline characteristics were 
assessed by means and linear regression (for continuous variables) or χ2 tests (for categorical 
variables). Three different models were used. First model was adjusted by age and 
examination year. In the second model, body mass index; smoking; physical activity; alcohol 
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intake were also adjusted for. Further adjusted on systolic blood pressure; diabetes; HDL 
cholesterol; LDL cholesterol; serum triglyceride; C - reactive protein was done in third model. 
Three different models were conducted to find out about the effect of different variables which 
may have the role as a confounders or modifier on the association between exposure and 
outcome. Associations between serum long chain PUFA, hair mercury content and stroke were 
analyzed using Cox regression models. Cohort mean was used to replace missing values in 
covariates (< 0.5%). Tests of linear trend were conducted by assigning the median values for 
each category of exposure variable and treating those as a single continuous variable. All P 
values were two-tailed (α = 0.05). Data were analyzed using SPSS 21.0 for Windows (SPSS 
Inc., Chicago, IL). 
 
5. Results 
5.1  Baseline characteristics 
There were no significant differences between serum long chain PUFA concentrations in those 
who had a stroke and those who did not (Table 5). In contrast, hair MeHg content was higher 
in those who had a stroke in comparison to those who did not have a stroke. 
141 cases of first strokes were identified, 107 cases out of 141 cases were ischemic stroke. At 
baseline, men with higher serum long-chain omega-3 PUFA concentration had a higher 
income, education, leisure-time physical activity, BMI, alcohol intake, serum LDL cholesterol, 
serum HDL cholesterol and hair mercury concentration and lower serum triglyceride 
concentration. They were also less likely to live in a rural area and smoke (Table 6). 
Men with higher hair mercury concentration were older; had a lower education, physical 
activity, income, and serum triglyceride concentrations; and had higher BMI, alcohol intake, 
serum long-chain omega-3 PUFA, HDL and LDL concentrations, and higher systolic and 
diastolic blood pressure. They were also more likely to live in a rural area and smoke (Table 
7). 
5.2  Association between serum long-chain omega-3 PUFA and risk of 
stroke 
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During the average follow-up of 16.1 years, 141 men (7.7%) developed stroke. Of all strokes, 
115 were ischemic strokes. After adjusted for age and year of examination (model 1 in Table 
8), higher serum long chain polyunsaturated fatty acids concentration was not statistically 
significantly associated with ischemic stroke and total stroke. Further multivariate adjustments 
did not have an appreciable effect on the association (Models 2& 3 in Table 8). Further 
adjustment for hair mercury slightly strengthened the association (RR in the highest quartile of 
total serum long-chain omega-3 PUFA 0.84, 95% CI 0.51-1.34, P for trend=0.55). There were 
no statistically significant associations when the individual fatty acids were evaluated 
separately (Table 8). 
The mean hair mercury concentration was 1.90 ug/g (SD 1.95). After adjusted for age and year 
of examination the risk of stroke in the highest vs. the lowest hair Hg quartile was increased 
by 59% [95% CI 0-154%, P for trend=0.01] (Model 1 in Table 9). Additional adjustments 
slightly attenuated the associations (Models 2&3 in Table 9). The associations were attenuated 
and not statistically significant, when only ischemic strokes were included in the analyses 
(Table 9). 
 
Table 5. Mean baseline concentrations of serum total long-chain omega-3 polyunsaturated 
fatty acids and hair mercury in those who experienced stroke and those who did not during the 
follow-up. 
 
 
Participants with 
stroke during follow-
up (n = 141), mean 
(SD) 
Participants without 
stroke during follow-
up (n = 1673), mean 
(SD) 
P value 
DHA, % 2.4 (0.7) 
 
2.5 (0.7) 0.8 
EPA, % 1.7 (0.8) 
 
1.7 (0.9) 0.9 
DPA, % 0.5 (0.1) 
 
0.5 (0.1) 0.3 
32 
 
Total omega 3 
PUFA, % 
4.7 (1.6) 
 
4.7 (1.6) 0.9 
Hairhg, ug/g 2.2 (1.9) 
 
1.9 (1.9) 0.05 
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Table 6. Baseline characteristics according to serum long-chain omega-3 PUFA concentration 
              Serum Omega 3 PUFA, % P value 
 Q1 
(0-0.64) 
Q2 
(0.65-1.26) 
Q3 
(1.27-
2.50) 
Q4 
(2.51-
15.67) 
 
Number of subjects 453 454 454 453 - 
Age (y) 52.2 (5.6) 52.1 (5.4) 52.6 (5.0) 52.7 (5.2) 0.05 
Education (y) 8.9 (3.3) 8.7 (3.4) 8.8 (3.5) 9.6 (4.0) < 0.001 
Marital status, married (%) 85 87 85 91 0.06 
Living in rural area (%) 30 28 28 25 0.40 
Leisure-time physical activity (kcal/d) 134 (171) 132 (155) 132 (146) 153 (196) 0.07 
Body mass index (kg/m2) 26.6 (3.5) 26.5 (3.3) 27 (3.5) 27 (3.5) 0.03 
Current smoker (%) 31 28 28 25 0.27 
Diabetes (%) 5 3 5 5 0.26 
Family history of stroke (%) 21 20 22 18 0.32 
Hypertension medication before stroke (%) 70 70 67 68 0.76 
Alcohol intake (g/wk) 55 (90) 62 (93) 85 (136) 85 (127) < 0.001 
Serum LDL, mmol/l 3.8 (0.3) 4.0 (0.9) 4.1 (1.0) 4.1 (1.0) < 0.001 
Serum HDL, mmol/l 1.2 (0.3) 1.3 (0.3) 1.3 (0.3) 1.4 (0.3) < 0.001 
Serum TG, mmol/l 1.5 (0.9) 1.3 (0.8) 1.1 (0.6) 1.0 (0.5) < 0.001 
Systolic blood pressure (mmHg) 135 (17) 134 (16) 134 (16) 134 (17) 0.98 
Diastolic blood pressure (mmHg) 90 (11) 89 (10) 89 (10) 89 (11) 0.97 
Hairhg, ug/g 1.2 (1.3) 1.6 (1.7) 2.2 (2) 2.7 (2.3) < 0.001 
Income, Euros 13344 
(7869) 
13833(9083
) 
14162 
(10070) 
15784 
(10360) 
< 0.001 
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 Table 7. Baseline characteristics according to hair mercury concentration 
 Hair Hg, ug/g P value 
  Q1 
(1.70-3.63) 
Q2 
(3.63-4.34) 
Q3 
(4.34-5.34) 
Q4 
(5.34-
15.59) 
 
Number of subjects 452 454 456 452 - 
Age (y) 51.0 (5.7) 51.8 (5.8) 52.8 (4.9) 54.0 (4.4) < 0.001 
Education (y) 9.7 (3.6) 9.6 (3.9) 8.8 (3.5) 7.8 (3) < 0.001 
Marital status, married (%) 86 91 87 84 0.12 
Living in rural area (%) 24 22 28 38 < 0.001 
Leisure-time physical activity (kcal/d) 154 (186) 143 (190) 134 (149) 120 (141) < 0.001 
Body mass index (kg/m2) 26.3 (3.2) 26.6 (3.3) 27.0 (3.6) 27.0 (3.7) < 0.001 
Current smoker (%) 25 25 26 36 < 0.001 
Diabetes (%) 4 4 5 5 0.58 
Family history of stroke (%) 21 19 21 21 0.85 
Hypertension medication before stroke 
(%) 
74 66 66 70 0.05 
Alcohol intake (g/wk) 60 (112) 73 (106) 76 (129) 78 (106) 0.05 
Serum LDL, mmol/l 3.8 (0.9) 3.9 (0.9) 4.0 (1) 4.3 (1) < 0.001 
Serum HDL, mmol/l 1.2 (0.9) 1.3 (0.3) 1.3 (0.3) 1.3 (0.3) < 0.001 
Serum TG, mmol/l 1.3 (0.8) 1.2 (0.7) 1.3 (0.9) 1.2 (0.6) 0.01 
EPA, % 1.3 (0.6) 1.6 (0.8) 1.7 (0.8) 2.1 (1.1) < 0.001 
DHA, % 2.2 (0.6) 2.4 (0.6) 2.5 (0.7) 2.7 (0.8) < 0.001 
DPA, % 0.5 (0.1) 0.5 (0.1) 0.6 (0.1) 0.6 (0.1) < 0.001 
Total omega 3 PUFA, % 4.0 (1.2) 4.5 (1.4) 4.8 (1.4) 5.4 (1.9) <0.001 
Systolic blood pressure (mmHg) 134 (17) 134 (16) 133 (16) 136 (16) 0.04 
Diastolic blood pressure (mmHg) 89.0 (10) 89.0 (10) 88.5 (11) 90.0 (10) 0.35 
Income Euros 15267 
(10033) 
15148 
(8617) 
14649 
(10260) 
12012 
(9428) 
< 0.001 
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Table 8. Risk of incident total stroke and ischemic stroke in quartiles of serum long-chain 
omega-3 polyunsaturated fatty acids  
 Serum long-chain Omega-3 PUFA, % 1 P  value 
for 
trend 
 Q1 Q2 Q3 Q4  
All stroke cases, (n=141) 
Total serum long-chain omega-3 polyunsaturated fatty acids 
 < 3.22 3.22-3.98 3.99-4.77 > 4.77  
No. of cases 36 29 38 38  
Model 1 1(referent) 0.76(0.46-1.24) 1.03 (0.65-
1.64) 
0.99 (0.63-
1.56) 
0.70 
Model 2 1(referent) 0.77(0.47-1.26) 1.02(0.64-
1.61) 
0.96(0.60-
1.52) 
0.86 
Model 3 1(referent) 0.78(0.48-1.28) 0.99(0.61-
1.60) 
0.91(0.56-
1.48) 
0.93 
EPA 
 < 0.92 0.92-1.27 1.28-1.67 > 1.67  
No. of cases 32 31 35 43  
Model 1 1(referent) 0.93 (0.56-
1.52) 
1.02 (0.63-
1.66) 
1.30(0.81-
2.07) 
0.17 
Model 2 1(referent) 0.96 (0.58-
1.58) 
1.02 (0.63-
1.66) 
1.20 (0.77-
1.99) 
0.28 
Model 3 1(referent) 0.93 (0.56-
1.55) 
0.99 (0.60-
1.65) 
1.16 (0.70-
1.93) 
0.43 
DHA 
 < 1.70 1.70-2.16 2.17-2.55 > 2.55  
No. of cases 35 29 37 40  
Model 1 1(referent) 0.80 (0.49-
1.31) 
1.05 (0.66-
1.66) 
1.08 (0.69-
1.71) 
0.49 
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Model 2 1(referent) 0.78 (0.48-
1.28) 
1.00 (0.63-
1.60) 
1.03 (0.65-
1.64) 
0.63 
Model 3 1(referent) 0.71 (0.43-
1.17) 
0.94 (0.58-
1.52) 
0.95 (0.59-
1.55) 
0.80 
DPA 
 < 0.44 0.44-0.51 0.52-0.58 > 0.58  
No. of cases 27 26 29 25  
Model 1 1(referent) 0.92 (0.59-
1.45) 
0.96 (0.61-
1.50) 
0.70 (0.43-
1.14) 
0.19 
Model 2 1(referent) 1.00 (0.63-
1.58) 
1.05 (0.67-
1.65) 
0.79 (0.48-
1.29) 
0.41 
Model 3 1(referent) 1.05 (0.66-
1.66) 
1.12 (0.70-
1.78) 
0.81 (0.49-
1.34) 
0.49 
Ischemic stroke, (n = 107 ) 
Total serum long-chain omega-3 polyunsaturated fatty acids 
 < 3.22 3.22-3.98 3.99-4.77 > 4.77  
No. of cases 29 21 26 31  
Model 1 1(referent) 0.68(0.39-1.20) 0.87(0.51-
1.47) 
1.00 (0.60-
1.67) 
0.66 
Model 2 1(referent) 0.70(0.40-1.22) 0.86(0.50-
1.47) 
0.99(0.59-
1.65) 
0.73 
Model 3 1(referent) 0.70(0.39-1.23) 0.82(0.47-
1.43) 
0.91(0.53-
1.58) 
0.96 
EPA 
 <0.92 0.92-1.27 1.28-1.67 > 1.67  
No. of cases 24 23 27 33  
Model 1 1(referent) 0.91 (0.52-
1.62) 
 1.04 (0.60-
1.82) 
1.32 (0.77-
2.25) 
0.20 
Model 2 1(referent) 0.97 (0.54-
1.72) 
1.06 (0.61-
1.85) 
1.30 (0.76-
2.40) 
0.26 
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Model 3 1(referent) 0.94 (0.53-
1.70) 
1.02 (0.57-
1.82) 
1.22 (0.69-
2.18) 
0.39 
DHA 
 < 1.70 1.70-2.16 2.17-2.55 > 2.55  
No. of cases 28 20 29 30  
Model 1 1(referent) 0.69 (0.39-
1.22) 
1.02 (0.61-
1.72) 
1.02 (0.61-
1.70) 
0.63 
Model 2 1(referent) 0.68 (0.38-
1.21) 
0.98 (0.58-
1.66) 
0.97 (0.57-
1.64) 
0.77 
Model 3 1(referent) 0.62 (0.35-
1.11) 
0.91 (0.53-
1.56) 
0.87 (0.50-
1.51) 
0.99 
DPA 
 < 0.44 0.44-0.51 0.52-0.58 > 0.58  
No. of cases 27 26 29 25  
Model 1 1(referent) 0.97 (0.57-
1.66) 
1.06 (0.63-
1.80) 
0.92 (0.53-
1.59) 
0.85 
Model 2 1(referent) 1.05 (0.61-
1.82) 
1.16 (0.68-
1.98) 
1.05 (0.60-
1.83) 
0.78 
Model 3 1(referent) 1.10 (0.64-
1.91) 
1.24 (0.72-
2.14) 
1.08 (0.61-
1.90) 
0.72 
      
1 Values in the models are relative risk (RRs) and 95% CIs (in parentheses). 
Model 1: adjusted for age and examination year. 
Model 2: adjusted for Model 1 plus body mass index; smoking; physical activity; alcohol 
intake;  
Model 3: adjusted for Model 2 plus systolic blood pressure; diabetes; HDL cholesterol; LDL 
cholesterol; serum triglyceride; C-Reactive Protein (each in quintiles). 
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Table 9. Risk of incident total stroke and ischemic stroke in quartiles of hair mercury  
 HairHg, ug/g 1 P 
value 
for 
trend 
  Q1 
(< 3.63) 
Q2 
(3.63-4.34) 
Q3 
(4.35-5.34) 
Q4 
(> 5.34) 
 
All stroke cases 
(n=141) 
     
No. of cases 25 24 21 37  
Model 1 1(referent) 0.95(0.57-
1.59) 
1.00 (0.60-
1.66) 
1.59 (1.00-
2.54) 
0.01 
Model 2 1(referent) 0.92 (0.55-
1.55) 
0.94 (0.56-
1.57) 
1.46 (0.91-
2.36) 
0.03 
Model 3 1(referent) 0.94 (0.56-
1.57) 
1.00 (0.60-
1.68) 
1.47 (0.90-
2.41) 
0.04 
Ischemic stroke  
(n = 107 ) 
     
No. of cases 29 21 26 31  
Model 1 1 (referent) 0.91 (0.52-
1.59) 
0.74 (0.41-
1.34) 
1.29 (0.77-
2.18) 
0.17 
Model 2 1 (referent) 0.90 (0.51-
1.58) 
0.71 (0.40-
1.29) 
1.24 (0.73-
2.11) 
0.22 
Model 3 1 (referent) 0.92 (0.52-
1.62) 
0.76 (0.42-
1.37) 
1.24 (0.72-
2.14) 
0.26 
1 Values in the models are relative risk (RRs) and 95% CIs (in parentheses). 
Model 1: adjusted for age and examination year. 
Model 2: adjusted for Model 1 plus body mass index; smoking; physical activity; alcohol 
intake;  
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Model 3: adjusted for Model 2 plus systolic blood pressure; diabetes; HDL cholesterol; LDL 
cholesterol; serum triglyceride; C-Reactive Protein (each in quintiles). 
 
6. Discussion 
Results from this population based cohort study suggest that a higher serum concentration of 
long-chain n-3 PUFA, mainly reflecting fatty fish consumption in this study population, does 
not have any association with total stroke and ischemic stroke. The results from this study 
suggest that exposure to methylmercury has a direct association with the risk of total stroke 
but not with the risk of ischemic stroke. Although we did not evaluate the association between 
methylmercury and hemorrhagic stroke separately due to the low number of participants with 
hemorrhagic stroke, the lower risk of ischemic stroke compared to the risk of total stroke 
suggests that methylmercury exposure increases especially the risk of hemorrhagic stroke.  
Some studies have pointed to the long-chain omega-3 PUFA as a risk factor for hemorrhagic 
stroke. Long-chain omega-3 PUFA have an effect on platelet aggregation (Park et al. 2009). 
Study done by Park et al. pointed to the positive association between EPA + DHA and 
hemorrhagic stroke in rat brains (Park et al. 2009). This effect has not been confirmed in 
humans. Few studies have evaluated the positive association between long-chain omega-3 
PUFA and risk of hemorrhage and bleeding disorders. However, none of them have 
considered the effect of high intake of long-chain omega-3 PUFA on increased bleeding 
through oxidative stress (Park et al. 2009). Although we did not have enough cases to study 
the association between serum long-chain omega-3 PUFA and risk of hemorrhagic strokes 
separately, it seems unlikely that there is an association because the associations with total and 
ischemic strokes were similar. Previously in this study population higher serum concentration 
of total long-chain omega-3 PUFA has been associated with lower systolic blood pressure and 
pulse pressure (Virtanen et al. 2012), CRP (Reinders et al. 2012), SCD (Virtanen et al. 2012), 
CHD and CVD (Virtanen et al. 2005) and also with the risk of atrial fibrillation (Virtanen et 
al. 2009). Atrial fibrillation is a common cardiac arrhythmia, and it is considered as one of the 
most important risk factors for stroke. Atrial fibrillation reduces the cardiac output and reduces 
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the cerebral blood flow, which has effect on stroke incident (Wolf et al. 1991). Atrial 
fibrillation can also significantly increase the frequency of blood clots that are transported into 
the carotid arteries by alteration in cardiac hemodynamics (Choi et al. 2013). However, inspite 
of the inverse association with the risk of atrial fibrillation, serum long-chain omega-3 PUFA 
do not seem to decrease the risk of stroke in this study population. 
The results of this study are consistent with the result from previous meta-analysis (Larsson 
and Orsini 2011, Xun et al. 2012) and with other cohort studies (Yuan et al. 2001, Folsom and 
Demissie 2004, Myint et al. 2006, Montonen et al. 2009), which could not find any inverse 
association between omega-3 PUFA and risk of stroke. However, opposite results have also 
been found (Iso et al. 2001, He et al. 2002, Larsson et al. 2011). The possible mechanism of 
the effect of fish consumption on stroke, especially ischemic stroke, could be explained by the 
effect of long-chain omega-3 PUFA from fatty fish. Omega-3 fatty acids from fatty fish 
influences blood pressure, lipid levels, inflammatory responses, red blood cell deformability, 
endothelial cell function, and cerebral arteriolar reactivity (Agren et al. 1990, Ellis et al. 1992, 
Knapp 1996, Nestel 2000). Each of these effects, separately or in combination, may plausibly 
reduce risk of ischemic stroke (Mozaffarian et al. 2005). Although each of these effects can 
have a role on reducing risk of ischemic stroke, this population cohort study could not find any 
beneficial effect of total serum long-chain n-3 PUFA or individual fatty acids separately with 
risk of stroke. Unlike with the other cardiovascular outcomes in this study cohort, high 
exposure to Hg does not seem to be the explanation, because adjustment for Hg only slightly 
strengthened the associations.  
Mozafarrian et al., explained the physiological effects and molecular pathways of n-3 PUFA 
that might influence CVD risk (Wu and Mozaffarian 2014). Omega 3 PUFA has effect on 
different physiological functions in different tissues, including heart, liver, vasculature, and 
circulating cells. Experimental studies show that n-3 PUFA has effect on cardiac 
electrophysiology, which could contribute to decrease in heart rate and arrhythmic risk (Wu 
and Mozaffarian 2014). n-3 PUFA reduce plasma triglyceride through decreasing very low-
density lipoprotein production in liver and increasing fatty acid beta-oxidation (Wu and 
Mozaffarian 2014). Blood pressure-lowering effect of n-3 PUFA is a result of reduced 
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systemic vascular resistance, which improves endothelial dysfunction, wall compliance, and 
vasodilatory responses. Physicochemical properties of cellular membranes are influenced by 
their lipid composition. n-3 PUFA have protective effect on CVD (Wu and Mozaffarian 2014) 
through  its role on membrane fluidity, ion channels function and gene expression via nuclear 
receptors and transcription factors. There are no comprehensive studies in regard to the effects 
on risk factors, molecular pathways, of protective effect of omega-3 PUFA and stroke. 
Although most of the risk factors for CVD and stroke are similar, we could not find any 
association between omega 3 PUFA and stroke. 
We used hair mercury as a reliable marker of long-term exposure (World Health Organization 
1990) . This study found a direct association between hair methylmercury content and risk of 
total stroke, which contradicts the null findings from the only previous study done by 
Mozaffarian et al (Mozaffarian et al. 2011). Several explanations may explain the conflicting 
results. Higher mercury level in the KIHD population could explain the different study 
findings. In the US cohort study the mean toenail mercury concentration was 0.44 µg/g in the 
male controls, corresponding to about 1.2 µg/g in hair (Mozaffarian et al. 2012). In our study 
the mean hair mercury concentration is 1.9 µg/g. Thus, in lower concentrations mercury may 
not have any adverse effects and higher levels of exposure are needed for the adverse effects. 
Also the effects of other factors, like dietary antioxidants and selenium, or differences in the 
genetic-based defenses, may explain the conflicting study findings.  
Hair methylmercury could also be a marker of other factors with possible effect on stroke risk. 
As seen in the Table 7, high hair mercury concentration has associated with stroke risk factors, 
such as systolic blood pressure, serum TG, body mass index. Other factors or residual 
confounding possibly can explain at least partly the higher risk in the highest hair mercury 
tertile. There were no significant differences in baseline serum long-chain omega-3 PUFA in 
those who experienced stroke during the follow-up and in those who did not. However, hair 
methylmercury concentration was higher in those who had a stroke (Table 5). Higher mercury 
content of selected fish or genetical differences in the elimination of mercury (Schlawicke 
Engstrom et al. 2008) could explain this.  
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Few studies have focused on the association between different risk factors and hemorrhagic 
stroke. Study done by Wang et al., pointed to the positive association between low total 
cholesterol and LDL-cholesterol levels and hemorrhagic stroke, especially intracerebral 
hemorrhage (ICH) (Wang et al. 2013). Also, there is an association between low intake of 
saturated fat and animal protein and increased risk of intraparenchymal hemorrhage (Iso et al. 
2001). Previous studies did not focus on the association between mercury exposure and 
different stroke types separately. Oxidative stress effect of methylmercury, which can decrease 
anti-oxidative capacity in plasma and cells and increase lipid peroxidation in cell membranes, 
could at least partly explain the association between mercury exposure and risk of stroke 
(Virtanen et al. 2005). Mercury also has high affinity to sulfhydryl groups, which results in 
inactivation of anti-oxidative thiolic compounds (Flora et al. 2008). In addition, mercury binds 
with selenium and forms an inactive form that cannot act as a catalytic center of glutathione 
peroxidase, a main scavenger of H2O2 and lipid peroxides (Virtanen et al. 2005). However, we 
do not have an explanation for why Hg would increase the risk of hemorrhagic stroke but not 
the risk of ischemic stroke. Further research is needed to elucidate the associations. 
Strength of the present study is the use of serum long-chain n-3 PUFA measurements instead 
of dietary intakes. Few prior studies have used circulating long-chain n-3 PUFA concentration 
as an exposure, which is important to reduce bias by misclassification that attenuates the 
associations in studies using dietary intakes. Serum long-chain n-3 PUFA concentration is a 
good biomarker of n3 fatty acid exposure (Hunter 1998). The other strength is the population-
based recruitment and high participation rate. Limitation of the study is the low number of 
stroke cases, especially hemorrhagic strokes and the participants were only men. 
 
7. Conclusions 
In summary, our findings suggest that circulating n3-PUFA levels are not associated with 
stroke. However, methylmercury exposure was associated with higher risk of total stroke. 
Although some studies have found an inverse association between serum omega 3 PUFA and 
stroke, there is not enough evidence about the specific amount of long-chain omega-3 PUFAs 
that is needed to reduce risk of stroke. Also, the amount of long-chain omega-3 PUFAs in 
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supplements is higher than what is commonly obtained from diet, so recommendation to take 
fish oil as a supplement instead of dietary fish intake should be done cautiously (He et al. 
2004).  
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